Patents by Inventor Christina Higgins

Christina Higgins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROSTATE ANTIGEN STANDARDS AND USES THEREOF
    Publication number: 20240159758
    Abstract: Aspects of the disclosure relate to improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer. In some embodiments, the disclosure provides improved prostate antigen standards for quantifying levels of prostate antigens.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: OPKO Diagnostics, LLC
    Inventors: Vincent Linder, Christina Higgins, Kim Pettersson
  • Prostate antigen standards and uses thereof
    Patent number: 11921115
    Abstract: Aspects of the disclosure relate to improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer. In some embodiments, the disclosure provides improved prostate antigen standards for quantifying levels of prostate antigens.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: March 5, 2024
    Assignee: OPKO Diagnostics, LLC
    Inventors: Vincent Linder, Christina Higgins, Kim Pettersson
  • PROSTATE ANTIGEN STANDARDS AND USES THEREOF
    Publication number: 20170370938
    Abstract: Aspects of the disclosure relate to improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer. In some embodiments, the disclosure provides improved prostate antigen standards for quantifying levels of prostate antigens.
    Type: Application
    Filed: March 25, 2016
    Publication date: December 28, 2017
    Applicant: OPKO Diagnostics, LLC
    Inventors: Vincent Linder, Christina Higgins
  • PROSTATE ANTIGEN STANDARDS AND USES THEREOF
    Publication number: 20160282349
    Abstract: Aspects of the disclosure relate to improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer. In some embodiments, the disclosure provides improved prostate antigen standards for quantifying levels of prostate antigens.
    Type: Application
    Filed: March 25, 2016
    Publication date: September 29, 2016
    Applicant: OPKO Diagnostics, LLC
    Inventors: Vincent Linder, Christina Higgins